Features

Gastroesophageal Reflux Disease (GERD)

Proton Pump Inhibitors and COVID-19: Is There an Increased Risk?

By

C. Andrew Kistler, MD, PharmD

A team of investigators assessed the potential for use of proton pump inhibitors to affect the risk of COVID-19 infection.

Microbiome

FMT Treatment Efficacy Evaluated for NAFLD

By

C. Andrew Kistler, MD, PharmD

As the role of the gut microbiome in nonalcoholic fatty liver disease is explored, research has turned to fecal microbiota transplantation as a potential treatment option.

Stomach Disorders

PPI Use and Dementia Development: Is There a Link?

By

C. Andrew Kistler, MD, PharmD

PPIs are frequently used off-label and are easily accessible as over-the-counter products, contributing to the potential for adverse events or drug-drug interactions.

Pancreatic Disorders

Diagnosing and Managing Patients With Primary Pancreatic Lymphoma

By

Roxanne Nelson, RN, BSN

Because primary pancreatic lymphoma is a rare disease, optimal diagnostic and therapeutic protocols have not yet been established.

Microbiome

Colorectal Cancer and the Gut Microbiome: What Are the Connections?

By

C. Andrew Kistler, MD, PharmD

The gut microbiome has become one of the most researched topics in gastroenterology. However, it is not yet understood how changes to the gut microbiome affect certain malignancies, particularly colorectal cancer (CRC). Despite improvements in detection and prevention by colonoscopy and other forms of testing, CRC still has a significant effect on patient morbidity and…

Colorectal neoplasia

Is Prophylactic Clipping Effective in Preventing Post-Polypectomy Bleeding?

By

Andy Kistler, MD, PharmD

Researchers conducted a meta-analysis to evaluate prophylactic clipping in preventing post-polypectomy bleeding and published the results in Gastroenterology.

Inflammatory Bowel Diseases (IBD)

Dual Biologic Therapy in Crohn’s Disease: A New Treatment Paradigm?

By

Andy Kistler, MD, PharmD

There is significant interest in optimizing medical treatments of Crohn’s disease (CD) in hopes of preventing complications and the need for surgery.

General Gastroenterology

COVID-19: Atypical GI Presentations

By

Andy Kistler, MD, PharmD

There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.

General Gastroenterology

The United States Test Against COVID-19

By

Utsav Aiya, MD

Mitigating the spread of a virus as infectious as SARS-CoV-2 requires having ample and accurate diagnostic tests available. However, in the United States, community transmission began to occur before adequate testing measures could be implemented.

General Gastroenterology

The Most Cases of COVID-19 Are in the United States: 5 Updates on the Pandemic

By

Natasha Priya Dyal, MD

The effects of the COVID-19 pandemic have caused more significant change than previously expected as the United States now has the most cases worldwide.

Inflammatory Bowel Diseases (IBD)

Ulcerative Colitis and Fecal Transplantation: Where are We Now?

By

Andy Kistler, MD, PharmD

It is thought that dysregulation of the gut microbiome could cause increased production of pro-inflammatory toxins that can predispose patients to the development of UC.

Microbiome

The Relationship Between Gut Microbiota and Neurodegenerative Disorders

By

Tori Rodriguez, MA, LPC, AHC

The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.

General Gastroenterology

Optimizing Dietary Habits to Combat COVID-19

By

Dibash Kumar Das, PhD

Many have emphasized the need to incorporate alternative strategies to reduce the long-term impacts of the COVID-19 pandemic.

General Gastroenterology

AGA Guidelines Regarding GI Procedures During the COVID-19 Pandemic

By

Andy Kistler, MD, PharmD

An area that has been specifically challenging within gastroenterology is the management of how and when to perform GI procedures, especially when many patients with COVID-19 have gastrointestinal (GI) symptoms.

Practice Management

Do Physician Rating and Ranking Sites Work?

By

Vivek Singh

In healthcare, the choices patients make can have direct consequences on their care. Nowhere is this more evident than in their choice of physician.

Liver

Neurocognitive Impairment in Chronic HCV Infection

By

Tori Rodriquez, MA, LPC, AHC

In the United States, approximately 3.5 million people are infected with the hepatitis C virus, which contributes to psychological and cognitive disorders for about half of all patients.

Esophagus

Barrett Esophagus Recurrence After Complete Eradication of Intestinal Metaplasia

By

Andy Kistler, MD, PharmD

Surveillance recommendations are based on the initial grade of dysplasia.

Liver

A Case of Hepatomegaly, Abdominal Pain, and Ascites

By

Mary-Kate Hunnicutt, PA-C

Alicia Elam, PharmD

Michael Felz, MD

Causes of Budd-Chiari syndrome include myeloproliferative syndromes, malignancy, infection, and Behҫet syndrome.

Inflammatory Bowel Diseases (IBD)

Etrasimod in UC: Promising Phase 2 Results

By

Andy Kistler, MD, PharmD

Researchers evaluated the efficacy and safety of etrasimod, an oral, selective sphingosine 1-phosphate receptor modulator in development for immune-mediated inflammatory disorders, in patients with moderate to severe ulcerative colitis.

Colorectal neoplasia

AF and Anticoagulation: Consider CRC in Patients With Lower GI Bleeding

By

Andy Kistler, MD, PharmD

The absolute 1-year risk of colorectal cancer in patients with atrial fibrillation treated with oral anticoagulants is not trivial.